Decision: Favourable
Study Title:
A multi-centre, single arm, open-label extension study to evaluate the long-term safety of GSK3511294 (Depemokimab) in adult and adolescent participants with severe asthma with an eosinophilic phenotype from studies 206713 or 213744
NREC Code:
22-NREC-CT-128
Decision:
Favourable
Meeting Date:
27/07/2022
Study Type:
CT application
Principal Investigator:
Dr Desmond Murphy
PI Institution:
Cork University Hospital
Sponsor:
GlaxoSmithKline Research & Development Limited